Beam Therapeutics Inc. vs UnitedHealth Group Incorporated — Stock Comparison
Beam Therapeutics Inc. (BEAM) and UnitedHealth Group Incorporated (UNH) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Beam Therapeutics Inc. and UnitedHealth Group Incorporated are evenly matched on Q·Score (6.1/10 each). UnitedHealth Group Incorporated scores higher on Quality, reflecting stronger profitability and returns. Analyst consensus targets imply greater upside for BEAM (+57.2%) than for UNH (+2.0%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Clean balance sheet with low leverage (0.2× debt-to-equity).
⚠ currently unprofitable (-40% margin).
82% of 28 covering analysts have a positive rating.
⚠ limited growth momentum.
Analyst Consensus
Fundamentals
Frequently Asked Questions
BEAM vs UNH: which stock scores better overall?
Based on Q·Score, Beam Therapeutics Inc. (BEAM) scores 6.1/10 versus UnitedHealth Group Incorporated (UNH) at 6.1/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: BEAM or UNH?
Beam Therapeutics Inc. (BEAM) scores higher on Growth (7.7/10 vs 5.1/10). Beam Therapeutics Inc. reports revenue growth (324.9% YoY) while UnitedHealth Group Incorporated reports (2.0% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is BEAM or UNH more attractively valued?
UnitedHealth Group Incorporated (UNH) scores higher on Valuation (6.5/10 vs 6.2/10). Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about BEAM vs UNH?
There are 15 analysts covering BEAM with a consensus price target of $51.07, and 26 analysts covering UNH with a consensus target of $407.38. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: BEAM or UNH?
UnitedHealth Group Incorporated (UNH) scores higher on Quality (5.9/10 vs 1.2/10). Net profit margin: BEAM at -40.2%, UNH at 2.7%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: BEAM or UNH?
Beam Therapeutics Inc. (BEAM) scores higher on Financial Health (9.2/10 vs 5.3/10). Market beta: BEAM at 2.20, UNH at 0.65. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of BEAM and UNH?
Beam Therapeutics Inc. (BEAM) has a market capitalisation of $3.3B, while UnitedHealth Group Incorporated (UNH) has a market cap of $362.8B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →